Skip to content

A Post-Market Clinical Trial for Access and Visualization of the Oropharynx, Hypopharynx and Larynx During Transoral Procedures

A Multicenter OUS Post-Market Clinical Follow-Up of the Medrobotics Flex® Robotic System Used for Accessing and Visualizing the Oropharynx, Hypopharynx, and Larynx During Transoral Procedures

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02262247
Enrollment
80
Registered
2014-10-13
Start date
2014-07-31
Completion date
2015-12-31
Last updated
2016-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypopharyngeal Neoplasms, Oral Disease, Oropharyngeal Neoplasms, OSA

Keywords

Transoral, Oropharynx, Hypopharynx, Endoscopic, TORS, Endoscopic Transoral, Larynx

Brief summary

The objectives of this study are to evaluate the performance of the Medrobotics Flex® Robotic System to visualize and access specific anatomical locations along with evaluation of the safety of the device.

Interventions

None listed

Sponsors

Medrobotics Corporation
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* ≥ 22 years of age * Candidate for transoral surgery in the oropharynx, hypopharynx and larynx

Exclusion criteria

* Less than 22 years of age * Not a candidate for transoral surgery in the oropharynx, hypopharynx and larynx

Design outcomes

Primary

MeasureTime frameDescription
Access and Visualizaton in Oropharynx, Hypopharynx and LarynxIntra-OperativeAbility to access and visualize all the following anatomical locations in the oropharynx, hypopharynx and larynx via transoral only approach. Palatine tonsils, base of tongue, epiglottis, posterior pharyngeal wall, false vocal cords.

Countries

Belgium, Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026